Parasuraman Ravi, Zhang Ping L, Samarapungavan Dilip, Rocher Leslie, Koffron Alan
Division of Transplantation and Department of Pathology, Royal Oak, MI 48703, USA ; Oakland University William Beaumont School of Medicine, William Beaumont Hospital, Royal Oak, MI 48703, USA.
Case Rep Transplant. 2013;2013:969186. doi: 10.1155/2013/969186. Epub 2013 Aug 28.
Adenoviruses (AdV) are emerging pathogens with a prevalence of 11% viruria and 6.5% viremia in kidney transplant recipients. Although AdV infection is common, interstitial nephritis (ADVIN) is rare with only 13 biopsy proven cases reported in the literature. We report a case of severe ADVIN with characteristic histological features that includes severe necrotizing granulomatous lesion with widespread tubular basement membrane rupture and hyperchromatic smudgy intranuclear inclusions in the tubular epithelial cells. The patient was asymptomatic at presentation, and the high AdV viral load (quantitative PCR>2,000,000 copies/mL in the urine and 646,642 copies/mL in the serum) confirmed the diagnosis. The patient showed excellent response to a combination of immunosuppression reduction, intravenous cidofovir, and immunoglobulin therapy resulting in complete resolution of infection and recovery of allograft function. Awareness of characteristic biopsy findings may help to clinch the diagnosis early which is essential since the disseminated infection is associated with high mortality of 18% in kidney transplant recipients. Cidofovir is considered the agent of choice for AdV infection in immunocompromised despite lack of randomized trials, and the addition of intravenous immunoglobulin may aid in resolution of infection while help prevention of rejection.
腺病毒(AdV)是一种新兴病原体,在肾移植受者中的患病率为11%的病毒尿症和6.5%的病毒血症。尽管AdV感染很常见,但间质性肾炎(ADVIN)却很罕见,文献中仅报道了13例经活检证实的病例。我们报告一例严重的ADVIN病例,其具有特征性组织学特征,包括严重的坏死性肉芽肿病变、广泛的肾小管基底膜破裂以及肾小管上皮细胞中嗜碱性模糊核内包涵体。该患者就诊时无症状,高AdV病毒载量(尿液定量PCR>2,000,000拷贝/mL,血清中646,642拷贝/mL)确诊了诊断。该患者对免疫抑制减少、静脉注射西多福韦和免疫球蛋白治疗的联合方案反应良好,感染完全消退,移植肾功能恢复。认识到特征性活检结果可能有助于早期确诊,这至关重要,因为播散性感染在肾移植受者中的死亡率高达18%。尽管缺乏随机试验,但西多福韦被认为是免疫功能低下患者AdV感染的首选药物,静脉注射免疫球蛋白的加入可能有助于感染的消退,同时有助于预防排斥反应。